2496 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Wuhan YZY Biopharma Co., Ltd. engages in the research, development, and industrialization of bispecific drugs. The firm specializes in tumor immunotherapy and immune cell therapy. Its business scope includes research and development of biotechnology, technology transfer, and technical advisory services; and wholesale and retail of biological drugs. The company was founded by Peng Fei Zhou, Qian Yuan, and Hong Feng Zhou on July 8, 2010 and is headquartered in Wuhan, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
2496 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company